Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
600 participants
OBSERVATIONAL
2014-01-01
2027-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cohort for Monitoring Patients With Venous Thromboembolic Disease
NCT07016542
Risk Factors for Venous Thromboembolism in the Community
NCT00011180
Epidemiology of Venous Thromboembolism
NCT00041457
Incidence and Outcomes of Venous Thromboembolism
NCT00005351
Epidemiology of Venous Thrombosis and Pulmonary Embolism
NCT00005504
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A search will be made in the clinical database for patients with the relevant diagnosis of CVT in the period between January 1, 2014, and December 31, 2023. Data from hospital charts will be linked with data from Statistics Norway (SSB), FD-Trygd, and Norwegian Prescription Database (NorPD). Using this combination of clinical data and health registries will make it possible to describe risk factors, clinical and radiological presentation, treatment and short-term outcome in a large Norwegian CVT cohort.
Further, data from hospitals will be linked with data from SSB, FD-Trygd, NorPD, Norwegian Patient Registry (NPR) and Cause of Death Registry (DÅR) up to five years after CVT. Using this methodology will make it possible to investigate overall long-term prognosis and outcomes in terms of mortality, health care utilisation, medication use and working situation up to five years after CVT in a large Norwegian cohort.
Lastly, a prospective follow-up study will include patients that have been diagnosed with CVT at the NoCVT hospitals during 2019-2023. By combining the collected data from the retrospective hospital chart review with the new follow-up interviews and self-reported questionnaires it will be possible to describe quality of life, vocational outcomes, psychological distress, depression, insomnia and disease-related disability in CVT.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oslo University Hospital
OTHER
Haukeland University Hospital
OTHER
Drammen sykehus
OTHER
Sorlandet Hospital HF
OTHER_GOV
St. Olavs Hospital
OTHER
Nordlandssykehuset HF
OTHER
University Hospital of North Norway
OTHER
University of Oslo
OTHER
Rigshospitalet, Denmark
OTHER
Hospital de Santa Maria, Portugal
OTHER
Sykehuset Innlandet HF
OTHER
Molde Hospital
OTHER
Helse Stavanger HF
OTHER_GOV
Sykehuset Telemark
OTHER_GOV
Sykehuset i Vestfold HF
OTHER
University Hospital, Akershus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Espen Saxhaug Kristoffersen
Principle Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Espen Saxhaug Kristoffersen, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Akershus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Akershus University Hospital
Lørenskog, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Kristoffersen ES, Harper CE, Vetvik KG, Zarnovicky S, Hansen JM, Faiz KW. Incidence and Mortality of Cerebral Venous Thrombosis in a Norwegian Population. Stroke. 2020 Oct;51(10):3023-3029. doi: 10.1161/STROKEAHA.120.030800. Epub 2020 Sep 4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NoCVT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.